Influence of P-glycoprotein and MRP efflux pump inhibitors on the intracellular activity of azithromycin and ciprofloxacin in macrophages infected by Listeria monocytogenes or Staphylococcus aureus
- PMID: 12697643
- DOI: 10.1093/jac/dkg223
Influence of P-glycoprotein and MRP efflux pump inhibitors on the intracellular activity of azithromycin and ciprofloxacin in macrophages infected by Listeria monocytogenes or Staphylococcus aureus
Abstract
Antibiotic efflux pumps expressed in eukaryotic cells can decrease the intracellular accumulation of the corresponding drugs and therefore impair their activity against intracellular bacteria. We have investigated whether verapamil (an inhibitor of P-glycoprotein) and gemfibrozil (an inhibitor of multidrug resistance proteins (MRP) and other organic anion transporters), can modulate the intracellular activity of azithromycin and ciprofloxacin against Listeria monocytogenes and Staphylococcus aureus in J774 macrophages. In parallel, we have measured the cell accumulation and subcellular distribution of both drugs. Antibiotics were used at equipotent extracellular concentrations (from 0.5 x to 10 x MIC) to allow for pharmacological comparisons. Azithromycin was bacteriostatic against L. monocytogenes and slightly bactericidal against S. aureus. Verapamil did not improve the maximal activity of azithromycin but allowed it to reach a similar effect at extracellular concentrations about seven-fold lower in both models. Azithromycin was predominantly localized in cell granules (66%), the remainder being in the cytosol and in the 'nuclei/unbroken cells' fraction. Verapamil increased the cellular accumulation of azithromycin by almost 2.4-fold without modifying its subcellular distribution. Ciprofloxacin displayed a strong concentration-dependent bactericidal activity in both models. Gemfibrozil increased ciprofloxacin activity almost 2.5-fold against L. monocytogenes, but not against S. aureus. Ciprofloxacin was predominantly (65%) distributed in the cytosol. Gemfibrozil increased ciprofloxacin total accumulation by approximately 2.4-fold, but the excess was only found in the cytosol. Inhibition of efflux pumps may be a useful strategy to improve antibiotic efficacy against intracellular bacteria when increased accumulation can be obtained in the compartment where bacteria sojourn.
Similar articles
-
Comparative activity of quinolones (ciprofloxacin, levofloxacin, moxifloxacin and garenoxacin) against extracellular and intracellular infection by Listeria monocytogenes and Staphylococcus aureus in J774 macrophages.J Antimicrob Chemother. 2005 Apr;55(4):511-7. doi: 10.1093/jac/dki059. Epub 2005 Feb 24. J Antimicrob Chemother. 2005. PMID: 15731197
-
Activity of finafloxacin, a novel fluoroquinolone with increased activity at acid pH, towards extracellular and intracellular Staphylococcus aureus, Listeria monocytogenes and Legionella pneumophila.Int J Antimicrob Agents. 2011 Jul;38(1):52-9. doi: 10.1016/j.ijantimicag.2011.03.002. Epub 2011 May 18. Int J Antimicrob Agents. 2011. PMID: 21596526
-
Cellular accumulation of fluoroquinolones is not predictive of their intracellular activity: studies with gemifloxacin, moxifloxacin and ciprofloxacin in a pharmacokinetic/pharmacodynamic model of uninfected and infected macrophages.Int J Antimicrob Agents. 2011 Sep;38(3):249-56. doi: 10.1016/j.ijantimicag.2011.05.011. Epub 2011 Jul 20. Int J Antimicrob Agents. 2011. PMID: 21764262
-
Reversal of resistance in microorganisms by help of non-antibiotics.J Antimicrob Chemother. 2007 Jun;59(6):1271-9. doi: 10.1093/jac/dkm071. Epub 2007 Apr 2. J Antimicrob Chemother. 2007. PMID: 17403708 Review.
-
Bacterial efflux pump inhibitors from natural sources.J Antimicrob Chemother. 2007 Jun;59(6):1247-60. doi: 10.1093/jac/dkl460. Epub 2006 Dec 4. J Antimicrob Chemother. 2007. PMID: 17145734 Review.
Cited by
-
Cellular accumulation and activity of quinolones in ciprofloxacin-resistant J774 macrophages.Antimicrob Agents Chemother. 2006 May;50(5):1689-95. doi: 10.1128/AAC.50.5.1689-1695.2006. Antimicrob Agents Chemother. 2006. PMID: 16641436 Free PMC article.
-
In vitro antibiotic activity against intraosteoblastic Staphylococcus aureus: a narrative review of the literature.J Antimicrob Chemother. 2021 Nov 12;76(12):3091-3102. doi: 10.1093/jac/dkab301. J Antimicrob Chemother. 2021. PMID: 34459881 Free PMC article. Review.
-
The Role of Metallic Nanoparticles in Inhibition of Mycobacterium Tuberculosis and Enhances Phagosome Maturation into the Infected Macrophage.Oman Med J. 2020 Nov 12;35(6):e194. doi: 10.5001/omj.2020.78. eCollection 2020 Nov. Oman Med J. 2020. PMID: 33214909 Free PMC article. Review.
-
Clinical application of development of nonantibiotic macrolides that correct inflammation-driven immune dysfunction in inflammatory skin diseases.Mediators Inflamm. 2012;2012:563709. doi: 10.1155/2012/563709. Epub 2012 Nov 1. Mediators Inflamm. 2012. PMID: 23258954 Free PMC article. Review.
-
Verapamil Increases the Bioavailability and Efficacy of Bedaquiline but Not Clofazimine in a Murine Model of Tuberculosis.Antimicrob Agents Chemother. 2017 Dec 21;62(1):e01692-17. doi: 10.1128/AAC.01692-17. Print 2018 Jan. Antimicrob Agents Chemother. 2017. PMID: 29038265 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical